“Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation
Pharmaceutical Statistics · 2026
DOI: 10.1002/pst.70080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2026. Verfasst von Emilie Højbjerre-Frandsen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics Methods, Novo Nordisk A/S, Søborg, Denmark. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Innovationsfonden.
Abstract (Originalsprache)
Adjustment for “super” or “prognostic” composite covariates has become more popular in randomized trials recently. These prognostic covariates are often constructed from historical data obtained from previous clinical trials or registries by fitting a predictive model of the outcome on the raw covariates. A natural question that we have been asked by applied researchers is whether this can be done without the historical data: can the prognostic covariate be constructed or derived from the trial data itself, possibly using different folds of the data, before adjusting for it? Here we clarify that such “within‐trial” prognostic adjustment is nothing more than a form of targeted maximum likelihood estimation (TMLE), a well‐studied procedure that typically improves the power of trial analyses. We therefore argue that there is no reason to reinvent the wheel: within‐trial prognostic score adjustment should be referred to as TMLE, without qualification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biostatistics Methods, Novo Nordisk A/S, Søborg, Denmark.
- Department of Mathematical Sciences, Aalborg University, Aalborg Øst, Denmark.
- Division of Biostatistics, University of California Berkeley, Berkeley, California, USA.
ORCID-Profile: Emilie Højbjerre-Frandsen
Förderung
- Innovationsfonden
Zitieren
APA
Højbjerre-Frandsen, E., & Schuler, A. (2026). “Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70080
Vancouver
Højbjerre-Frandsen E, Schuler A. “Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation. Pharmaceutical Statistics. 2026. doi:10.1002/pst.70080
BibTeX
@article{HjbjerreFrandsen2026,
author = {Højbjerre-Frandsen, Emilie and Schuler, Alejandro},
title = {“Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation},
journal = {Pharmaceutical Statistics},
year = {2026},
doi = {10.1002/pst.70080}
}
EUVIMED